Gebelik ve Emzirme Döneminde Baş Ağrısı Yönetimi
Özet
Gebelik ve laktasyon dönemlerinde, hormonal ve dolaşım fizyolojisindeki özgün değişimler nedeniyle baş ağrısı semptomlarının değerlendirilmesi, ayırıcı tanısının yapılması ve farmakolojik yönetimi kritik öneme sahiptir. Bu dönemdeki baş ağrıları sıklıkla primer tipte (migren, gerilim tipi) olsa da; "kırmızı bayrak" belirtilerinin (ani başlangıçlı gök gürültüsü tarzı ağrı, fokal nörolojik defisit) varlığında sekonder nedenler (preeklampsi/eklampsi, Serebral Venöz Tromboz, PRES, RCVS) titizlikle araştırılmalıdır. Gebeliğin ikinci ve üçüncü trimesterlerinde östrojenin stabilizasyonuyla migren atakları azalma eğilimi gösterirken , postpartum dönemde hormonal dalgalanma , yeni doğana bakım verme stresi ve uyku eksikliği gibi nedenlerle migren atak sıklığı artabilmektedir.Tedavide, özellikle organogenez dönemi olan ilk trimesterde non-farmakolojik yaklaşımlar (düzenli uyku, gevşeme teknikleri, yoga) öncelikle düşünülmelidir. Akut atakta ilk basamak ajan, FDA B kategorisinde yer alan ve süte geçiş oranı düşük olan asetaminofendir. Non-steroid anti-inflamatuar ilaçlar (NSAİİ), fetüste duktus arteriozusun erken kapanması riakini arttırdığı için üçüncü trimesterde kontrendike kabul edilir. Şiddetli ve asetaminofene yanıtsız migren atakları için sumatriptan, görece güvenli bir seçenek olarak değerlendirilmektedir. Profilaktik tedavide ise düşük doz propranolol veya düşük doz amitriptilin önerilmektedir; valproik asit ve topiramat gibi yüksek teratojenik potansiyele sahip antiepileptiklerden kaçınılması gerekmektedir. Gebelik ve emzirme döneminde baş ağrısı yönetimi, bireyselleştirilmiş, dikkatli ve multidisipliner bir yaklaşımla ele alınmalıdır.
Referanslar
O’Neal Mary Angela, “Headaches complicating pregnancy and the postpartum period,” Pract Neurol, vol. 17, pp. 191–202, May 2017.
Patel Shital J., Reede Deborah L., Katz Douglas S., Subramaniam Raja, and Amorosa Judith K., “Imaging the Pregnant Patient for Nonobstetric Conditions: Algorithms and Radiation Dose Considerations,” RadioGraphics, vol. 27, no. 6, Nov. 2007.
R. Huna-Baron and M. J. Kupersmith, “Idiopathic intracranial hypertension in pregnancy,” J Neurol, vol. 249, no. 8, pp. 1078–1081, 2002, doi: 10.1007/s00415-002-0791-4.
E. Berzan, R. Doyle, and C. M. Brown, “Treatment of Preeclampsia: Current Approach and Future Perspectives,” Sep. 01, 2014, Current Medicine Group LLC 1. doi: 10.1007/s11906-014-0473-5.
T. Podymow and P. August, “Antihypertensive Drugs in Pregnancy,” Semin Nephrol, vol. 31, no. 1, pp. 70–85, Jan. 2011, doi: 10.1016/j.semnephrol.2010.10.007.
A. B. Singhal et al., “Reversible cerebral vasoconstriction syndromes: Analysis of 139 cases,” Arch Neurol, vol. 68, no. 8, pp. 1005–1012, Aug. 2011, doi: 10.1001/archneurol.2011.68.
C. Capatina, W. Inder, N. Karavitaki, and J. A. H. Wass, “Management of endocrine disease: Pituitary tumour apoplexy,” May 01, 2015, BioScientifica Ltd. doi: 10.1530/EJE-14-0794.
J. M. Ferro, P. Canhão, J. Stam, M. G. Bousser, and F. Barinagarrementeria, “Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT),” Stroke, vol. 35, no. 3, pp. 664–670, Mar. 2004, doi: 10.1161/01.STR.0000117571.76197.26.
S. K. Feske and A. B. Singhal, “Cerebrovascular Disorders Complicating Pregnancy.” [Online]. Available: www.ContinuumJournal.com
R. Barati-Boldaji, S. Shojaei-Zarghani, M. Mehrabi, A. Amini, and A. R. Safarpour, “Post-dural puncture headache prevention and treatment with aminophylline or theophylline: a systematic review and meta-analysis,” Anesth Pain Med (Seoul), vol. 18, no. 2, pp. 177–189, 2023, doi: 10.17085/apm.22247.
D. Katz and Y. Beilin, “Review of the alternatives to epidural blood patch for treatment of postdural puncture headache in the parturient,” 2017, Lippincott Williams and Wilkins. doi: 10.1213/ANE.0000000000001840.
K. G. Vetvik and E. A. MacGregor, “Menstrual migraine: a distinct disorder needing greater recognition,” Apr. 01, 2021, Lancet Publishing Group. doi: 10.1016/S1474-4422(20)30482-8.
G. Allais, G. Chiarle, S. Sinigaglia, G. Airola, P. Schiapparelli, and C. Benedetto, “Estrogen, migraine, and vascular risk,” Jun. 01, 2018, Springer-Verlag Italia s.r.l. doi: 10.1007/s10072-018-3333-2.
Saldanha Ian J. et al., “Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review,” The Journal of Headache and Facial Pain, vol. 61, no. 1, pp. 11–43, Jan. 2021.
A. Negro et al., “Headache and pregnancy: a systematic review,” Dec. 01, 2017, Springer-Verlag Italia s.r.l. doi: 10.1186/s10194-017-0816-0.
Q. Jiang, Z. Wu, L. Zhou, J. Dunlop, and P. Chen, “Effects of Yoga Intervention during Pregnancy: A Review for Current Status,” May 01, 2015, Thieme Medical Publishers, Inc. doi: 10.1055/s-0034-1396701.
K. Linde, G. Allais, B. Brinkhaus, E. Manheimer, A. Vickers, and A. R. White, “Acupuncture for migraine prophylaxis,” 2009. doi: 10.1002/14651858.CD001218.pub2.
T. J. Steiner, L. J. Stovner, R. Jensen, D. Uluduz, and Z. Katsarava, “Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019,” Dec. 01, 2020, BioMed Central Ltd. doi: 10.1186/s10194-020-01208-0.
H. Tezel Yalçın, N. Yalçın, M. Ceulemans, and K. Allegaert, “Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed®,” Pharmaceuticals, vol. 17, no. 12, Dec. 2024, doi: 10.3390/ph17121654.
MacGregor EA. Headache in pregnancy. Continuum (Minneap Minn). 2014;20(1):128–147. doi:10.1212/01.CON.0000443841.40933.9eli
S. Amundsen, H. Nordeng, K. Nezvalová-Henriksen, L. J. acob Stovner, and O. Spigset, “Pharmacological treatment of migraine during pregnancy and breastfeeding,” Nat Rev Neurol, vol. 11, no. 4, pp. 209–219, Apr. 2015, doi: 10.1038/nrneurol.2015.29.
Brandlistuen Ragnhild Eek, Ystrom Eivind, Nulman Irena, Koren Gideon, and Nordeng Hedvig, “Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study,” Int J Epidemiol, vol. 42, no. 6, pp. 1702–1713, Dec. 2013.
Liew Zeyan, Ritz Beate, and Rebordosa Cristina, “Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders,” AMA Pediatrics, vol. 168, no. 4, pp. 313–320, Feb. 2014.
E. Yilmaz and I. Ünal Çevik, “Headache in challenging and special circumstances: Pregnancy and lactation,” 2018, Turkish Society of Algology. doi: 10.5505/agri.2018.85688.
S. Amundsen, H. Nordeng, K. Nezvalová-Henriksen, L. J. acob Stovner, and O. Spigset, “Pharmacological treatment of migraine during pregnancy and breastfeeding,” Nat Rev Neurol, vol. 11, no. 4, pp. 209–219, Apr. 2015, doi: 10.1038/nrneurol.2015.29.
O. P. Soldin, J. Dahlin, and D. M. O’Mara, “Triptans in pregnancy,” Feb. 2008. doi: 10.1097/FTD.0b013e318162c89b.
B. Källén, ; Per, and E. Lygner, “Delivery Outcome in Women Who Used Drugs for Migraine During Pregnancy With Special Reference to Sumatriptan.”
K. Nezvalová-Henriksen, O. Spigset, and H. Nordeng, “Triptan safety during pregnancy: A Norwegian population registry study,” Eur J Epidemiol, vol. 28, no. 9, pp. 759–769, Sep. 2013, doi: 10.1007/s10654-013-9831-x.
R. Burch, “Acute Treatment of Migraine,” 2024.
S. Amundsen, T. G. Øvrebø, N. M. S. Amble, A. C. Poole, and H. Nordeng, “Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women,” Eur J Clin Pharmacol, vol. 72, no. 12, pp. 1525–1535, Dec. 2016, doi: 10.1007/s00228-016-2127-9.
S. Hutchinson, M. J. Marmura, A. Calhoun, S. Lucas, S. Silberstein, and B. L. Peterlin, “Use of common migraine treatments in breast-feeding women: A summary of recommendations,” Apr. 2013. doi: 10.1111/head.12064.
N. González-García et al., “Headache: pregnancy and breastfeeding. Recommendations of the Spanish Society of Neurology’s Headache Study Group,” Neurología (English Edition), vol. 37, no. 1, pp. 1–12, Jan. 2022, doi: 10.1016/j.nrleng.2018.12.023.
P. K. Winner et al., “Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study,” Drug Saf, vol. 42, no. 8, pp. 1013–1024, Aug. 2019, doi: 10.1007/s40264-019-00824-3.
F. Cheng and F. Ahmed, “OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation,” Expert Opin Drug Saf, vol. 20, no. 11, pp. 1275–1289, 2021, doi: 10.1080/14740338.2021.1948531.
E. Uyar Türkyilmaz et al., “Bilateral greater occipital nerve block for treatment of post-dural puncture headache after caesarean operations.”
S. K. Parikh, M. V. Delbono, and S. D. Silberstein, “Managing migraine in pregnancy and breastfeeding,” in Progress in Brain Research, vol. 255, Elsevier B.V., 2020, pp. 275–309. doi: 10.1016/bs.pbr.2020.07.011.
S. Holland, S. Silberstein, F. F. Freitag, D. D. Dodick, C. Argoff, and E. Ashman, “Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults DESCRIPTION OF THE ANALYTIC PROCESS,” 2011. [Online]. Available: www.neurology.org
R. E. Wells, D. P. Turner, M. Lee, L. Bishop, and L. Strauss, “Managing Migraine During Pregnancy and Lactation,” Apr. 01, 2016, Current Medicine Group LLC 1. doi: 10.1007/s11910-016-0634-9.
“Our study demonstrates the safety of 100-Hz screens, confirming previous observations.5 There-fore, in screen-sensitive subjects, the use of 100-Hz screens instead of conventional 50-Hz screens must be considered a nonpharmacologic countermeasures for seizures,” 1998.
R. Burch, “Headache in Pregnancy and the Puerperium,” Feb. 01, 2019, W.B. Saunders. doi: 10.1016/j.ncl.2018.09.004.
M. Makrides, D. D. Crosby, E. Bain, and C. A. Crowther, “Magnesium supplementation in pregnancy,” Apr. 03, 2014, John Wiley and Sons Ltd. doi: 10.1002/14651858.CD000937.pub2.
“Effects of pregnancy and female steroid hormones on CGRP synthesis.” [Online]. Available: http://tem.trends.com
S. Sacco et al., “European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update,” Dec. 01, 2022, BioMed Central Ltd. doi: 10.1186/s10194-022-01431-x.
S. K. Parikh and S. D. Silberstein, “Preventive Treatment for Episodic Migraine,” Nov. 01, 2019, W.B. Saunders. doi: 10.1016/j.ncl.2019.07.004.
R. Bhola et al., “Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program,” Journal of Headache and Pain, vol. 16, no. 1, Dec. 2015, doi: 10.1186/s10194-015-0535-3.
A. Judkins, R. L. Johnson, S. T. Murray, S. M. Yellon, and C. G. Wilson, “Vagus nerve stimulation in pregnant rats and effects on inflammatory markers in the brainstem of neonates,” Pediatr Res, vol. 83, no. 2, pp. 514–519, Feb. 2018, doi: 10.1038/pr.2017.265.
D. Yarnitsky et al., “Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial,” Headache, vol. 59, no. 8, pp. 1240–1252, Sep. 2019, doi: 10.1111/head.13551.
